Medicago begins trials for Covid-19 vaccine using tobacco-like plant

Medicago begins trials for Covid-19 vaccine using tobacco-like plant

- A Canadian biotech company is one of the companies in the world trying to develop a vaccine for the Covid-19 virus

- However, Medicago is taking a different route as they are using plants for their potential vaccine

- The company began phase one clinical trials yesterday and are hopeful for positive results

PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly.co.za News on your News Feed!

The pharmaceutical industry, research institutions, multi-national corporations and governments all over the world are all scrambling to develop the world's first Covid-19 vaccine.

One Canadian biotech firm has been using plants to attempt to develop a potential vaccine. Medicago, headed in Quebec, began phase one clinical trials on 14 July, administering the first doses to healthy human volunteers.

Medicago is also planning a phase two/three trial to be initiated in October.

Medicago is using an Australian tobacco-like plant to try and develop a Covid-19 vaccine.

Medicago is using an Australian tobacco-like plant to try and develop a Covid-19 vaccine.
Source: UGC

READ ALSO: SADTU wants schools to close until peak of the Covid-19 virus passes

News24 reported that Medicago is one of 23 candidates that have reached phase one clinical trials in the race to develop a vaccine that will curb the spread of the Covid-19 virus.

Medicago has been using plants to develop potential vaccines for more than two decades. It is backed by large investors like Mitsubishi Tanabe Pharma and Philip Morris International Inc.

Last week, the company also signed a deal with GlaxoSmithKline, agreeing to pair the vaccine with the UK giant’s adjuvants, boosters that can help any brand of shot.

Medicago relies on an Australian plant that’s a close relative to tobacco, known as nicotiana benthamiana, to develop vaccines.

The plant has a weakened immune system that allows it to easily host genetic material and develop particles that mimic a virus.

Meanwhile, Briefly.co.za reported that Russia has completed human trials of their Covid-19 vaccine.

Elena Smolyarchuk from the Russian Center for Clinical Research on Medications at Sechenow University said that test patients are set to be discharged soon.

Smolyarchuk added that the research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20.

However, there is no indication as to when the vaccine will enter commercial production, but nevertheless this bodes well for the global fight against the virus.

Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!

Source: Briefly.co.za

Mailfire view pixel